MBM Wealth Consultants’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
MBM Wealth Consultants's VRTX Position: Q3 2026 in Review
MBM Wealth Consultants increased its Vertex Pharmaceuticals (VRTX) stake by 4.9% in Q3 2026, buying an estimated $120K and bringing the position to 4,984 shares worth $2.61M. The position accounts for 0.48% of the portfolio, ranked #29.
MBM Wealth Consultants first reported a position in VRTX in Q4 2020 and has held it in 24 quarters since. 1,796 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- MBM Wealth Consultants held 4,984 shares of Vertex Pharmaceuticals worth $2.61M as of Q3 2026.
- MBM Wealth Consultants bought 234 Vertex Pharmaceuticals shares in Q3 2026, an estimated $120K.
- Vertex Pharmaceuticals made up 0.48% of MBM Wealth Consultants's portfolio in Q3 2026, its #29 holding.
- MBM Wealth Consultants first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- 1,796 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on MBM Wealth Consultants's 13F filing for Q3 2026, filed 20 Oct 2026.